Related Experiment Video

Updated: May 6, 2026

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
07:40

Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model

Published on: January 12, 2022

5.3K

Psoriatic juvenile idiopathic arthritis associated with uveitis: a case report

Davide Moretti1, Ilaria Cianchi, Gaia Vannucci

  • 1Rheumatology Unit, Department of Paediatrics, University of Florence, Anna Meyer Children's Hospital, Viale Pieraccini 24, 50139 Firenze, Italy.

Case Reports in Rheumatology
|November 6, 2013
PubMed

Insights

Psoriatic juvenile idiopathic arthritis (JIA) can cause chronic uveitis. Adalimumab effectively treated a child with psoriatic JIA and uveitis who previously failed other therapies, achieving sustained remission.

Area of Science:

  • Rheumatology
  • Ophthalmology
  • Pediatrics

Background:

  • Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in children, leading to significant disability.
  • Psoriatic JIA, a subtype, affects up to 10% of JIA cases and carries a 10-15% risk of chronic uveitis.
  • Uveitis in psoriatic JIA poses a significant challenge, often requiring advanced treatment strategies.

Purpose of the Study:

  • To report a case of psoriatic JIA with associated uveitis.
  • To evaluate the efficacy of adalimumab in a pediatric patient refractory to conventional treatments.
  • To highlight a successful therapeutic outcome for a complex JIA case.

Main Methods:

  • Case report of a pediatric patient diagnosed with psoriatic JIA and uveitis.
  • Review of previous treatment failures including NSAIDs, methotrexate, and etanercept.
  • Initiation and monitoring of adalimumab therapy.

Main Results:

  • The patient experienced persistent arthritis and uveitis despite multiple prior treatments.
  • Adalimumab administration resulted in sustained clinical remission of both arthritis and uveitis.
  • The treatment demonstrated significant efficacy in a challenging JIA case.

Conclusions:

  • Adalimumab is a viable and effective treatment option for psoriatic JIA complicated by uveitis.
  • This case underscores the importance of targeted biologic therapy in refractory JIA.
  • Successful management of psoriatic JIA with uveitis can be achieved with appropriate advanced therapies.

More Related Videos

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

15.8K
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients02:28

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients

Published on: March 1, 2024

1.1K

Related Concept Videos

Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
1.2K
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
424
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
64
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
2.4K
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
762
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
75